Search

everythinglearnresearchcommunity

for

Search:↓

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Upadacitinib improved multiple immune-related conditions in one patient.

Stress causes hair loss by disrupting hair growth cycles, and combining medical and cosmetic treatments can help manage it.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Centella asiatica extract may help promote hair growth by blocking a specific cell signaling pathway.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Three compounds from Dadap leaves may help treat hair loss.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Specific miRNA profiles can help diagnose and treat alopecia areata.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Certain circular RNAs are crucial for wool growth and curvature in goats.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

New treatments for seborrheic dermatitis show promise for difficult cases.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Effective PCOS treatments require targeting specific signaling pathways.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.